NEU 0.29% $20.81 neuren pharmaceuticals limited

Share Price, page-10799

  1. 5,761 Posts.
    lightbulb Created with Sketch. 308
    Daybue sales are a key element.
    Increase of patients moving onto Daybue,
    Return of patients having dropped off Daybue.
    And retention rates of those on Daybue.

    This gives a good sign post of revenue/profit for NEU. And thus SP calc + milestones coming + “growth factor” for Europe/other territories and NZ2591



 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.